{"id":54828,"date":"2023-03-14T19:03:12","date_gmt":"2023-03-14T18:03:12","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\/"},"modified":"2023-03-14T19:03:12","modified_gmt":"2023-03-14T18:03:12","slug":"seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\/","title":{"rendered":"SeqOne Genomics Appoints Herv\u00e9 Pouzoullic as Chief Commercial Officer"},"content":{"rendered":"
\n

\nA seasoned leader in the pharmaceutical and diagnostics industry, <\/i><\/b>specialized in structuring international healthcare sales joins the team to accelerate international expansion<\/i><\/b>\n<\/p>\n

MONTPELLIER, France–(BUSINESS WIRE)–SeqOne Genomics, provider of next generation genomic analysis solutions for personalized medicine, announces the appointment of Herv\u00e9 Pouzoullic as Chief Commercial Officer (CCO). He will lead the commercial development of the company to accelerate its growth and strengthen its international presence.<\/b>\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nHerv\u00e9 has more than 25 years of experience in sales, business development and general management. He worked at KPMG, Sanofi and, ThermoFisher Scientific in Europe, Asia and North America before joining SeqOne. He has extensive knowledge of the diagnostics and pharmaceutical industry where he has established strategic partnerships with leading messenger RNA companies ahead of the COVID pandemic. Herv\u00e9 holds a Master’s degree in Finance from Paris Dauphine PSL University, graduated from Sciences-Po Paris (Finance Marketing) and INSEAD (Cedep).\n<\/p>\n

\nSeqOne\u2019s platform analyses genomic data in both cancer and inherited disease to support precision medicine programs. Its solution is relied upon by a growing number of hospitals and private medical laboratories, as well as for biopharmas seeking to harness the potential of genomics in drug discovery. The recruitment of Herv\u00e9 Pouzoullic will enable the company to expand its offer worldwide.\n<\/p>\n

\n“I am honored to join SeqOne to build a sales team with international ambitions and look forward to promoting innovative solutions that enable access to personalized medicine, for people living with cancer and rare diseases<\/i>,” said Herv\u00e9 Pouzoullic CCO of SeqOne Genomics.<\/b>\n<\/p>\n

\n\u00ab At a time when SeqOne is strengthening its leadership with the integration of experts from the world of health and the biopharmaceutical industry, we are particularly pleased to welcome Herv\u00e9 who brings an impressive track record. He will strengthen SeqOne’s position in genomic medicine internationally. ” <\/i>said Nicolas Philippe, CEO and co-founder of SeqOne Genomics.<\/b>\n<\/p>\n

\nAbout SeqOne Genomics
\n
<\/b>SeqOne Genomics specializes in high-performance genomic analysis solutions for use in healthcare and life science – hospitals, research institutions, and pharmaceutical companies. SeqOne\u2019s mission is to make genomic analysis more accessible and effective, in order to improve treatments for patients suffering from cancer, rare and hereditary deseases as well as pharmaceutical companies developing new therapies.
\n
SeqOne\u2019s platform supports both short read and long-read nanopore sequencing and leverages advanced machine learning coupled with the company\u2019s proprietary genomics operating system to dramatically reduce turnaround times and costs while delivering comprehensive andactionable insights for personalized medicine. https:\/\/www.seqone.com\/<\/a><\/b>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nContact SeqOne Genomics<\/b> :
\n
Jean-Marc Holder \u2013 jm.holder@seqone.com<\/a>\n<\/p>\n

\nContact presse SeqOne<\/b> :
\n
Annie-Florence Loyer – afloyer@newcap.fr<\/a> \/ +33 (6) 88 20 35 59\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

A seasoned leader in the pharmaceutical and diagnostics industry, specialized in structuring international healthcare sales joins the team to accelerate international expansion MONTPELLIER, France–(BUSINESS WIRE)–SeqOne Genomics, provider of next generation genomic analysis solutions for personalized medicine, announces the appointment of Herv\u00e9 Pouzoullic as Chief Commercial Officer (CCO). He will lead the commercial development of the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-54828","format-standard","category-industry"],"yoast_head":"\nSeqOne Genomics Appoints Herv\u00e9 Pouzoullic as Chief Commercial Officer - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SeqOne Genomics Appoints Herv\u00e9 Pouzoullic as Chief Commercial Officer - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"A seasoned leader in the pharmaceutical and diagnostics industry, specialized in structuring international healthcare sales joins the team to accelerate international expansion MONTPELLIER, France–(BUSINESS WIRE)–SeqOne Genomics, provider of next generation genomic analysis solutions for personalized medicine, announces the appointment of Herv\u00e9 Pouzoullic as Chief Commercial Officer (CCO). He will lead the commercial development of the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-14T18:03:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230314005886\/en\/1738343\/21\/Herv%C3%A9_Pouzoullic.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"SeqOne Genomics Appoints Herv\u00e9 Pouzoullic as Chief Commercial Officer\",\"datePublished\":\"2023-03-14T18:03:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\\\/\"},\"wordCount\":435,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230314005886\\\/en\\\/1738343\\\/21\\\/Herv%C3%A9_Pouzoullic.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\\\/\",\"name\":\"SeqOne Genomics Appoints Herv\u00e9 Pouzoullic as Chief Commercial Officer - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230314005886\\\/en\\\/1738343\\\/21\\\/Herv%C3%A9_Pouzoullic.jpg\",\"datePublished\":\"2023-03-14T18:03:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230314005886\\\/en\\\/1738343\\\/21\\\/Herv%C3%A9_Pouzoullic.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230314005886\\\/en\\\/1738343\\\/21\\\/Herv%C3%A9_Pouzoullic.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SeqOne Genomics Appoints Herv\u00e9 Pouzoullic as Chief Commercial Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SeqOne Genomics Appoints Herv\u00e9 Pouzoullic as Chief Commercial Officer - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\/","og_locale":"en_US","og_type":"article","og_title":"SeqOne Genomics Appoints Herv\u00e9 Pouzoullic as Chief Commercial Officer - Pharma Trend","og_description":"A seasoned leader in the pharmaceutical and diagnostics industry, specialized in structuring international healthcare sales joins the team to accelerate international expansion MONTPELLIER, France–(BUSINESS WIRE)–SeqOne Genomics, provider of next generation genomic analysis solutions for personalized medicine, announces the appointment of Herv\u00e9 Pouzoullic as Chief Commercial Officer (CCO). He will lead the commercial development of the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-14T18:03:12+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230314005886\/en\/1738343\/21\/Herv%C3%A9_Pouzoullic.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"SeqOne Genomics Appoints Herv\u00e9 Pouzoullic as Chief Commercial Officer","datePublished":"2023-03-14T18:03:12+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\/"},"wordCount":435,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230314005886\/en\/1738343\/21\/Herv%C3%A9_Pouzoullic.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\/","url":"https:\/\/pharma-trend.com\/en\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\/","name":"SeqOne Genomics Appoints Herv\u00e9 Pouzoullic as Chief Commercial Officer - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230314005886\/en\/1738343\/21\/Herv%C3%A9_Pouzoullic.jpg","datePublished":"2023-03-14T18:03:12+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230314005886\/en\/1738343\/21\/Herv%C3%A9_Pouzoullic.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230314005886\/en\/1738343\/21\/Herv%C3%A9_Pouzoullic.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/seqone-genomics-appoints-herve-pouzoullic-as-chief-commercial-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"SeqOne Genomics Appoints Herv\u00e9 Pouzoullic as Chief Commercial Officer"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54828","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54828"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54828\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54828"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54828"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54828"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}